Notably, linkage to chr17 or INPP5K mutations were excluded in 29 families and isolated case subjects presenting with an incomplete phenotype, i.e., either skeletal muscular disease or early cataracts together with variable additional clinical manifestations (mainly polyneuropathy, cerebellar atrophy, or other brain malformations). This evidence concerns the gene INPP5K and polyneuropathy.